SCLX

Scilex Holding Company is a biopharmaceutical innovator based in Palo Alto, California, focused on the development and commercialization of non-opioid therapeutics for acute and chronic pain management. With a strong commitment to improving patient outcomes and reducing opioid dependency, Scilex leverages advanced research and development to create effective pain relief solutions that meet the evolving needs of healthcare providers and patients alike. The company is positioned to play a pivotal role in transforming the pain management landscape, offering alternative options that enhance quality of life for individuals suffering from debilitating pain.